|
|
||||||||
Ann Thorac Surg 1996;61:546-550
© 1996 The Society of Thoracic Surgeons
Divisions of Thoracic Surgery and Neurosurgery, Tochigi Cancer Center, Utsunomiya, Japan
Accepted for publication October 28, 1995.
Background. Brain metastases are a common mode of recurrence in resected lung cancer and are usually associated with an ominous outcome.
Methods. To assess the usefulness of follow-up using computed tomography of the brain for early detection and effective treatment of brain metastases, we prospectively studied 128 patients with completely resected nonsmall cell lung cancer. Follow-up computed tomographic scans were obtained every 2 to 6 months over 24 postoperative months in 69 patients and every 2 months for 6 postoperative months in 59.
Results. Brain metastases were discovered in 11 patients (8.6%), and 7 patients were neurologically asymptomatic when the metastases were diagnosed. Single metastasis was found in 5 patients and multiple metastases in 6. The maximal size of all but one lesion was less than 25 mm. The median survival time and 5-year survival rate in all 11 patients with brain metastases were 10 months and 24%, respectively. Furthermore, those in 7 asymptomatic patients were 25 months and 38%, respectively.
Conclusions. We consider intensive follow-up with computed tomography to be worthwhile for early detection and effective treatment of brain metastases in patients with completely resected lung cancer.
Related Article
Ann. Thorac. Surg. 1996 61: 551.
This article has been cited by other articles:
![]() |
D. Srikantharajah, A. Ghuman, M. Nagendran, and M. Maruthappu Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival? Interact CardioVasc Thorac Surg, November 1, 2012; 15(5): 893 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
Lung cancer: what's new in diagnosis and therapies? Thorax, December 1, 2009; 64(Suppl_4): A80 - A85. [Full Text] [PDF] |
||||
![]() |
K. E. Posther, L. M. McCall, D. H. Harpole Jr., C. E. Reed, J. B. Putnam Jr., V. W. Rusch, and B. A. Siegel Yield of Brain 18F-FDG PET in Evaluating Patients with Potentially Operable Non-Small Cell Lung Cancer J. Nucl. Med., October 1, 2006; 47(10): 1607 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Marom, H. P. McAdams, J. J. Erasmus, P. C. Goodman, D. K. Culhane, R. E. Coleman, J. E. Herndon, and E. F. Patz Jr Staging Non-Small Cell Lung Cancer with Whole-Body PET Radiology, September 1, 1999; 212(3): 803 - 809. [Abstract] [Full Text] |
||||
![]() |
F. E. IV, J. H. Ryu, G. M. Miller, P. H. Luetmer, L. A. Forstrom, O. L. Burnett, C. M. Rowland, S. J. Swensen, and D. E. Midthun Suspected Non–Small Cell Lung Cancer: Incidence of Occult Brain and Skeletal Metastases and Effectiveness of Imaging for Detection—Pilot Study Radiology, April 1, 1999; 211(1): 137 - 145. [Abstract] [Full Text] |
||||
![]() |
C. A.B. Saunders, J. E. Dussek, M. J. O'Doherty, and M. N. Maisey Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer Ann. Thorac. Surg., March 1, 1999; 67(3): 790 - 797. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |